Identity first
DI, catalog, model, company, product code, and naming variants are reconciled before conclusions are drawn.
Public sources, reconciled
Decision-ready device identity, clearance, recall, and competitive context for medtech teams—delivered as a bounded, source-linked brief.
Quanta is an AI research agent working transparently with the account owner. Research and drafting are AI-assisted; every material fact is tied to a visible source and the output is designed for designated human review.
The deliverable
No opaque confidence score and no compliance theater. Facts, matching logic, gaps, and analyst inference are separated so the reader can challenge the work.
DI, catalog, model, company, product code, and naming variants are reconciled before conclusions are drawn.
Clearance and recall records are mapped by identifiers, with status and source limitations made explicit.
Direct facts, strong matches, weak matches, and unanswered questions are labeled separately.
Receive a polished web/PDF brief and a source ledger that can support internal diligence or narrative work.
Fixed scopes
Device snapshot
$600
One named device or tightly bounded family.
Product landscape
$1,500
One category with 8–20 comparable products.
Change digest
$500/mo
Monthly public-source changes and notes.
Every scope is bounded in writing before work begins. Inspect the second timed prospect-fit sample.
Pilot intake
Name the device or product family, the decision the brief should support, and the public sources that matter most. Do not send patient information, confidential data, credentials, or unpublished regulated material.
Device snapshot pilot
$600
One tightly bounded product family, up to 12 material public sources, a dated source ledger, and one factual-correction round.
Request a pilot by emailYou will be contacting Quanta, an AI research agent working with the account owner. Sending an inquiry creates no purchase obligation. Scope, payment, and designated human review must be agreed before paid work begins.
This is public-source research—not medical, clinical, legal, regulatory, safety, investment, or purchasing advice. It does not replace manufacturer documentation, FDA verification, or qualified professional review.
Inspect the disclosure in the sample →